Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04598698 · ClinicalTrials.gov registry record

The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA

A clinical trial of Endometriosis, sponsored by Dot Laboratories.

Active
Registry status
750
Enrollment target
20
Study locations

NCT04598698 is a study of Endometriosis that is active but no longer recruiting, run by Dot Laboratories. The registered enrollment target is 750 participants, above the 249-participant average among 48 other Endometriosis trials with a reported enrollment target (201% higher). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04598698, a study of Endometriosis, is active but no longer recruiting, sponsored by Dot Laboratories.

ACTIVE NOT RECRUITING
Registry status
750 participants
Enrollment target
20
Study locations

Study Summary

Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visits for collection of blood and saliva and completion of study questionnaires.

Conditions Studied

Endometriosis

Study Locations (20)

Illinois

  • Northwestern Medicine - Chicago
  • NorthShore University HealthSystem - Evanston
  • The Advanced Gynecologic Surgery Institute - Park Ridge

California

  • Stanford University Hospital - Palo Alto
  • Center for Special Minimally Invasive & Robotic Surgery - Woodside

Delaware

  • Christiana Care - Newark
  • RAD Fertility - Newark

Ohio

  • University Hospitals - Cleveland
  • Cleveland Clinic - Cleveland

Pennsylvania

  • Penn State Health - Hershey
  • Hospital of the University of Pennsylvania - Philadelphia

Connecticut

  • Yale University - New Haven

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Florida

  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2020-11-02
Est. Completion 2024-12

Sponsor

Dot Laboratories

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04598698

The ClinicalTrials.gov registry entry for NCT04598698 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 249-participant average among 48 other Endometriosis trials with a reported enrollment target (201% higher). The listed sponsor is Dot Laboratories, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 0 interventions.

NCT04598698 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Illinois, California, Delaware.

Frequently Asked Questions

What is clinical trial NCT04598698 about?

NCT04598698 is a clinical study titled "The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA". Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal ris...

What is the current status of trial NCT04598698?

This trial is currently active not recruiting. The enrollment target is 750 participants. The study started on 2020-11-02. Estimated completion is 2024-12.

What conditions does trial NCT04598698 study?

This clinical trial studies the following conditions: Endometriosis.

Who is sponsoring clinical trial NCT04598698?

This trial is sponsored by Dot Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04598698 being conducted?

This trial has 20 study locations across California, Connecticut, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometriosis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.